Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Trine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, Marie Beck Enemark, Kristina Lystlund Lauridsen, Stephen Hamilton-Dutoit, Claus Andersen, Michael Boe Møller, Søren Schwartz Sørensen, Bente Jespersen, Jan Kampmann, Francesco d’Amore & Maja Ludvigsen. (2021) Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder. Acta Oncologica 60:12, pages 1637-1642.
Read now
Read now
Amelie Kinch, Eva Baecklund, Daniel Molin, Karlis Pauksens, Christer Sundström, Gunnar Tufveson & Gunilla Enblad. (2021) Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders. Acta Oncologica 60:6, pages 771-778.
Read now
Read now
Amelie Kinch, Rose-Marie Amini, Peter Hollander, Daniel Molin, Christer Sundström & Gunilla Enblad. (2020) CD30 expression and survival in posttransplant lymphoproliferative disorders. Acta Oncologica 59:6, pages 673-680.
Read now
Read now
Jan Styczynski. (2017) Managing post-transplant lymphoproliferative disorder. Expert Opinion on Orphan Drugs 5:1, pages 19-35.
Read now
Read now
Articles from other publishers (26)
Jennifer E. Amengual & Barbara Pro. (2023) How I treat posttransplant lymphoproliferative disorder. Blood 142:17, pages 1426-1437.
Crossref
Crossref
Noriaki Kawano, Yamada Kyohei, Hiroaki Miyoshi, Noriaki Yoshida, Kouichi Ohshima, Fumiko Arakawa, Kazutaka Nakashima, Takuro Kameda, Yasunori Kogure, Yuta Ito, Shuro Yoshida, Takuro Kuriyama, Takashi Nakaike, Taro Tochigi, Ken Takigawa, Kiyoshi Yamashita, Atsushi Toyofuku, Tatsuya Manabe, Atsushi Doi, Soushi Terasaka, Kouske Marutsuka, Hidenobu Ochiai, Ikuo Kikuchi, Yasuo Mori, Keisuke Kataoka, Tomoharu Yoshizumi, Junji Yamauchi, Yoshihisa Yamano & Kazuya Shimoda. (2023) The development of adult T cell leukemia/lymphoma in renal transplant recipients: report of two cases with literature review. Renal Replacement Therapy 9:1.
Crossref
Crossref
Suheil Albert Atallah‐Yunes, Omar Salman & Michael J. Robertson. (2023) Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies. British Journal of Haematology 201:3, pages 383-395.
Crossref
Crossref
Mariam Markouli, Fauzia Ullah, Najiullah Omar, Anna Apostolopoulou, Puneet Dhillon, Panagiotis Diamantopoulos, Joshua Dower, Carmelo Gurnari, Sairah Ahmed & Danai Dima. (2022) Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder. Cancers 14:23, pages 5949.
Crossref
Crossref
Daan Dierickx, Martyna Pociupany & Yaso Natkunam. (2022) Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatment. Current Opinion in Oncology 34:5, pages 413-421.
Crossref
Crossref
Roland SchwartingEric BehlingAshleigh AllenVivian Arguello-GuerraTulin Budak-Alpdogan. (2022) CD30+ Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted Therapies. Archives of Pathology & Laboratory Medicine 146:4, pages 415-432.
Crossref
Crossref
Akihiro Ohmoto & Shigeo Fuji. (2021) Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders. Blood Reviews 49, pages 100807.
Crossref
Crossref
Erika Orlandi, Giuseppe Carlo Iorio, Sara Bartoncini, Elena Gallio, Federica Cavallo, Federica Santoro, Umberto Ricardi & Mario Levis. (2021) Role of Radiotherapy in Post-transplant Lymphoproliferative Disorders: Three Case Reports and Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 21:4, pages e309-e316.
Crossref
Crossref
Eva González-Barca, Francisco Javier Capote, Jose Gómez-Codina, Carlos Panizo, Antonio Salar, Juan-Manuel Sancho, Andres López, Javier Briones, Andres Muñoz, Maite Encuentra, Santiago Mercadal, Eva Domingo-Domenech & Alberto Fernández de Sevilla. (2020) Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients. Annals of Hematology 100:4, pages 1023-1029.
Crossref
Crossref
Francesca Montanari & Manuela Orjuela-Grimm. (2021) Joining Efforts for PTLD: Lessons Learned from Comparing the Approach and Treatment Strategies Across the Pediatric and Adult Age Spectra. Current Hematologic Malignancy Reports 16:1, pages 52-60.
Crossref
Crossref
Patrizia Comoli & Jan Styczynski. 2021. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
221
237
.
Lydia Montes, Estelle Tredez, Clara Yzet, Caroline Delette, Denis Chatelain, Delphine Lebon, Mathurin Fumery & Jean‐Pierre Marolleau. (2020) Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30. Clinical Case Reports 8:6, pages 958-961.
Crossref
Crossref
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W. Keller, Michael Prummer, Laurent Hoffmann, Janice K. P. Lam, Alan K. S. Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D. Lünemann, Michael Kammüller & Christian Münz. (2020) Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLOS Pathogens 16:4, pages e1008477.
Crossref
Crossref
Huan Dong, Qiang Wang, Guosen Zhang, Ning Li, Mengsi Yang, Yang An, Longxiang Xie, Huimin Li, Lu Zhang, Wan Zhu, Shuchun Zhao, Haiyu Zhang & Xiangqian Guo. (2020) OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma. Cancer Medicine 9:5, pages 1790-1797.
Crossref
Crossref
Fedaey Abbas, Mohsen El Kossi, Ihab Sakr Shaheen, Ajay Sharma & Ahmed Halawa. (2020) Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World Journal of Transplantation 10:2, pages 29-46.
Crossref
Crossref
Thomas Mika, Katharina Strate, Swetlana Ladigan, Clemens Aigner, Uwe Schlegel, Iris Tischoff, Sabine Tischer-Zimmermann, Britta Eiz-Vesper, Britta Maecker-Kolhoff & Roland Schroers. (2019) Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes. Frontiers in Medicine 6.
Crossref
Crossref
Ioannis Anagnostopoulos & Leticia Quintanilla de Fend. 2019. Pathologie. Pathologie
717
792
.
Ashley V. Geerlinks, Thomas G. Gross & Angela S. Punnett. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
195
211
.
Rebecca E. Schultze-Florey & Britta Maecker-Kolhoff. (2018) Transplantationsassoziierte lymphoproliferative Erkrankungen (PTLD) bei KindernPost-transplant lymphoproliferative diseases in children. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 32:6, pages 502-509.
Crossref
Crossref
Daan DierickxThomas M. Habermann. (2018) Post-Transplantation Lymphoproliferative Disorders in Adults. New England Journal of Medicine 378:6, pages 549-562.
Crossref
Crossref
Christopher Hartley, James W Vaughan, Jason Jarzembowski, Steven H Kroft, Paul Hosking, Alexandra M Harrington & Horatiu Olteanu. (2017) CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration. American Journal of Clinical Pathology 148:6, pages 485-493.
Crossref
Crossref
Navin K. KesariSanjeev SivakumarAvni M. KapadiaWendy ChenClifford R. BliedenChethan P. Venkatasubba RaoJose I. Suarez. (2017) Mystery Case: CNS posttransplant lymphoproliferative disorder. Neurology 89:4.
Crossref
Crossref
Maja Ølholm Vase, Maja Ludvigsen, Knud Bendix, Stephen Hamilton-Dutoit, Michael Boe Mller, Court Pedersen, Gitte Pedersen, Niels Obel, Carsten Schade Larsen, Francesco d’Amore & Bent Honoré. (2016) Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development. AIDS 30:12, pages 1889-1898.
Crossref
Crossref
Mira Choi, Susanne Fink, Vikas Prasad, Ioannis Anagnostopoulos, Petra Reinke & Clemens A. Schmitt. (2016) T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy. Transplantation 100:3, pages e8-e10.
Crossref
Crossref
Maja Ølholm Vase, Eva Futtrup Maksten, Charlotte Strandhave, Esben Søndergaard, Knud Bendix, Stephen Hamilton-Dutoit, Claus Andersen, Michael Boe Møller, Søren Schwartz Sørensen, Jan Kampmann, Hans Eiskjær, Martin Iversen, Ilse Duus Weinreich, Bjarne Møller, Bente Jespersen & Francesco d'Amore. (2015) HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort. Transplantation Direct 1:7, pages e25.
Crossref
Crossref
Vincent Thomas de Montpréville, Jérôme Le Pavec, François Le Roy Ladurie, Adrian Crutu, Sacha Mussot, Dominique Fabre, Olaf Mercier, Peter Dorfmuller, Maria-Rosa Ghigna & Élie Fadel. (2015) Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms. Respiration 90:6, pages 451-459.
Crossref
Crossref